Cargando…

NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA

PURPOSE: The current study aims to test the hypothesis that the ratio of T1-weighted image to T2-weighted image signal intensity (T1w/T2w-Ratio: rT1/T2), an imaging surrogate developed for myelin integrity, is predictive of histologically lower-grade glioma's IDH mutation status. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanada, Takahiro, Yamamoto, Shota, Sakai, Mio, Umehara, Toru, Sato, Hirotaka, Saito, Masato, Mitsui, Nobuyuki, Hiroshima, Satoru, Anei, Ryogo, Kanemura, Yonehiro, Tanino, Mishie, Nakanishi, Katsuyuki, Kishima, Haruhiko, Kinoshita, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719351/
http://dx.doi.org/10.1093/noajnl/vdac167.066
_version_ 1784843304962097152
author Sanada, Takahiro
Yamamoto, Shota
Sakai, Mio
Umehara, Toru
Sato, Hirotaka
Saito, Masato
Mitsui, Nobuyuki
Hiroshima, Satoru
Anei, Ryogo
Kanemura, Yonehiro
Tanino, Mishie
Nakanishi, Katsuyuki
Kishima, Haruhiko
Kinoshita, Manabu
author_facet Sanada, Takahiro
Yamamoto, Shota
Sakai, Mio
Umehara, Toru
Sato, Hirotaka
Saito, Masato
Mitsui, Nobuyuki
Hiroshima, Satoru
Anei, Ryogo
Kanemura, Yonehiro
Tanino, Mishie
Nakanishi, Katsuyuki
Kishima, Haruhiko
Kinoshita, Manabu
author_sort Sanada, Takahiro
collection PubMed
description PURPOSE: The current study aims to test the hypothesis that the ratio of T1-weighted image to T2-weighted image signal intensity (T1w/T2w-Ratio: rT1/T2), an imaging surrogate developed for myelin integrity, is predictive of histologically lower-grade glioma's IDH mutation status. MATERIALS AND METHODS: 25 histologically and molecularly confirmed lower-grade glioma patients with eight IDH-wildtype (IDHwt) and 17 IDH-mutant (IDHmt) tumors at Asahikawa Medical University Hospital (AMUH) were used as a test cohort. Twenty-nine patients (IDHwt: 13, IDHmt: 16) from Osaka International Cancer Institute (OICI) and 101 patients from the Cancer Imaging Archive (TCIA) / Cancer Genome Atlas (TCGA) dataset (IDHwt: 19, IDHmt: 82) were used as external cohorts. rT1/T2 images were calculated from T1- and T2-weighted images using a recommended signal correction. The relationship between the mean rT1/T2 (mrT1/T2) and the IDH mutation status was investigated. Moreover, t-Distributed Stochastic Neighbor Embedding (t-SNE) investigated the difference in MRI qualities and characteristics between the three cohorts. RESULTS: The test cohort at AMUH revealed that mrT1/T2 of IDHwt tumors was significantly higher than that of IDHmt tumors (p < 0.05) and that the optimal cut-off of mrT1/T2 for discriminating IDHmt was 0.666-0.677, (AUC = 0.75, p < 0.05), which finding was validated by the external domestic cohort at OICI (AUC = 0.75, p = 0.02). However, the external international cohort deriving from TCIA/TCGA could not validate this (AUC = 0.63, p = 0.08). t-SNE analysis revealed that the difference in image characteristics within the cohort was more diverse for the TCIA/TCGA than for the two domestic cohorts. CONCLUSION: The current study revealed that mrT1/T2 was able to discriminate IDHwt and IDHmt tumors in two domestic cohorts significantly. This was not validated by the TCIA/TCGA cohort due to the wide variety in the original imaging characteristics of the TCIA/TCGA cohort.
format Online
Article
Text
id pubmed-9719351
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97193512022-12-06 NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA Sanada, Takahiro Yamamoto, Shota Sakai, Mio Umehara, Toru Sato, Hirotaka Saito, Masato Mitsui, Nobuyuki Hiroshima, Satoru Anei, Ryogo Kanemura, Yonehiro Tanino, Mishie Nakanishi, Katsuyuki Kishima, Haruhiko Kinoshita, Manabu Neurooncol Adv Abstracts PURPOSE: The current study aims to test the hypothesis that the ratio of T1-weighted image to T2-weighted image signal intensity (T1w/T2w-Ratio: rT1/T2), an imaging surrogate developed for myelin integrity, is predictive of histologically lower-grade glioma's IDH mutation status. MATERIALS AND METHODS: 25 histologically and molecularly confirmed lower-grade glioma patients with eight IDH-wildtype (IDHwt) and 17 IDH-mutant (IDHmt) tumors at Asahikawa Medical University Hospital (AMUH) were used as a test cohort. Twenty-nine patients (IDHwt: 13, IDHmt: 16) from Osaka International Cancer Institute (OICI) and 101 patients from the Cancer Imaging Archive (TCIA) / Cancer Genome Atlas (TCGA) dataset (IDHwt: 19, IDHmt: 82) were used as external cohorts. rT1/T2 images were calculated from T1- and T2-weighted images using a recommended signal correction. The relationship between the mean rT1/T2 (mrT1/T2) and the IDH mutation status was investigated. Moreover, t-Distributed Stochastic Neighbor Embedding (t-SNE) investigated the difference in MRI qualities and characteristics between the three cohorts. RESULTS: The test cohort at AMUH revealed that mrT1/T2 of IDHwt tumors was significantly higher than that of IDHmt tumors (p < 0.05) and that the optimal cut-off of mrT1/T2 for discriminating IDHmt was 0.666-0.677, (AUC = 0.75, p < 0.05), which finding was validated by the external domestic cohort at OICI (AUC = 0.75, p = 0.02). However, the external international cohort deriving from TCIA/TCGA could not validate this (AUC = 0.63, p = 0.08). t-SNE analysis revealed that the difference in image characteristics within the cohort was more diverse for the TCIA/TCGA than for the two domestic cohorts. CONCLUSION: The current study revealed that mrT1/T2 was able to discriminate IDHwt and IDHmt tumors in two domestic cohorts significantly. This was not validated by the TCIA/TCGA cohort due to the wide variety in the original imaging characteristics of the TCIA/TCGA cohort. Oxford University Press 2022-12-03 /pmc/articles/PMC9719351/ http://dx.doi.org/10.1093/noajnl/vdac167.066 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Sanada, Takahiro
Yamamoto, Shota
Sakai, Mio
Umehara, Toru
Sato, Hirotaka
Saito, Masato
Mitsui, Nobuyuki
Hiroshima, Satoru
Anei, Ryogo
Kanemura, Yonehiro
Tanino, Mishie
Nakanishi, Katsuyuki
Kishima, Haruhiko
Kinoshita, Manabu
NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
title NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
title_full NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
title_fullStr NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
title_full_unstemmed NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
title_short NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
title_sort ni-13 the ratio of t1-weighted to t2-weighted signal intensity and idh mutation in glioma
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719351/
http://dx.doi.org/10.1093/noajnl/vdac167.066
work_keys_str_mv AT sanadatakahiro ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT yamamotoshota ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT sakaimio ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT umeharatoru ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT satohirotaka ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT saitomasato ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT mitsuinobuyuki ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT hiroshimasatoru ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT aneiryogo ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT kanemurayonehiro ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT taninomishie ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT nakanishikatsuyuki ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT kishimaharuhiko ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma
AT kinoshitamanabu ni13theratiooft1weightedtot2weightedsignalintensityandidhmutationinglioma